Chemogen Overview

  • Founded
  • 2000
  • Status
  • Private
  • Employees
  • 7
  • Latest Deal Type
  • Series D
  • Latest Deal Amount
  • $3.08M
Latest Deal Amount
  • Investors
  • 2

Chemogen General Information


Developer of novel diagnostic tests designed for the diagnosis of tuberculosis (TB) in immunocompromised people. The company's test is used for the diagnosis of active tuberculosis by detection of urinary lipoarabinomannan (uLAM) from Mycobacterium tuberculosis, enabling doctors to diagnose patients with tuberculosis efficiently.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Diagnostic Equipment
Primary Office
  • 125 John Roberts Road
  • Suite 5
  • South Portland, ME 04106
  • United States
+1 (207) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Chemogen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series D) 05-May-2006 $3.08M 00.000 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 28-Apr-2004 00.000 00.000 00.000 Completed Generating Revenue
2. Secondary Transaction - Private $802K Completed Startup
1. Early Stage VC 26-Dec-2001 $802K $802K 00.00 Completed Startup
To view Chemogen’s complete valuation and funding history, request access »

Chemogen Board Members (1)

Name Representing Role Since
Robert Flory Self Chairman 000 0000
To view Chemogen’s complete board members history, request access »

Chemogen Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Chemogen Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Maine Venture Fund Venture Capital Minority 000 0000 000000 0
Masthead Venture Partners Venture Capital Minority 000 0000 000000 0
To view Chemogen’s complete investors history, request access »